Mostrar el registro sencillo del ítem
| dc.contributor.author | Valiente-Soriano, Francisco-Javier | |
| dc.contributor.author | Ortin-Martínez, Arturo | |
| dc.contributor.author | Di-Pierdomenico, Johnny | |
| dc.contributor.author | García-Ayuso, Diego | |
| dc.contributor.author | Gallego-Ortega, Alejandro | |
| dc.contributor.author | Miralles-de-Imperial-Ollero, Juan-A | |
| dc.contributor.author | Jiménez-López, Manuel | |
| dc.contributor.author | Villegas-Pérez, María-Paz | |
| dc.contributor.author | Wheeler, Larry-A | |
| dc.contributor.author | Vidal-Sanz, Manuel | |
| dc.date.accessioned | 2026-02-12T11:25:57Z | |
| dc.date.available | 2026-02-12T11:25:57Z | |
| dc.date.issued | 2019-11 | |
| dc.identifier.citation | Valiente-Soriano FJ, Ortín-Martínez A, Di Pierdomenico J, García-Ayuso D, Gallego-Ortega A, Miralles De Imperial-Ollero JA, et al. Topical Brimonidine or Intravitreal BDNF, CNTF, or bFGF Protect Cones Against Phototoxicity. Trans Vis Sci Tech. 17 de diciembre de 2019;8(6):36. | |
| dc.identifier.issn | 2164-2591 | |
| dc.identifier.uri | https://sms.carm.es/ricsmur/handle/123456789/24112 | |
| dc.description.abstract | PURPOSE: To develop a focal photoreceptor degeneration model by blue light-emitting diode (LED)-induced phototoxicity (LIP) and investigate the protective effects of topical brimonidine (BMD) or intravitreal brain-derived neurotrophic factor (BDNF), ciliary neurotrophic factor (CNTF), or basic fibroblast growth factor (bFGF). METHODS: In anesthetized, dark-adapted, adult female Swiss mice, the left eye was dilated and exposed to blue light (10 seconds, 200 lux). After LIP, full-field electroretinograms (ERG) and spectral-domain optical coherence tomography (SD-OCT) were obtained longitudinally, and reactive-Iba-1(+)monocytic cells, TUNEL(+) cells and S-opsin(+) cone outer segments were examined up to 7 days. Left eyes were treated topically with BMD (1%) or vehicle, before or right after LIP, or intravitreally with BDNF (2.5 ?g), CNTF (0.2 ?g), bFGF (0.5 ?g), or corresponding vehicle right after LIP. At 7 days, S-opsin(+) cone outer segments were counted within predetermined fixed-size areas (PFA) centered on the lesion in both flattened retinas. RESULTS: SD-OCT showed a circular region in the superior-temporal left retina with progressive thinning (207.9 ± 5.6 ?m to 160.7 ± 6.8 ?m [7 days], n = 8), increasing TUNEL(+) cells (peak at 3 days), decreasing S-opsin(+) cone outer segments, and strong microglia activation. ERGs were normal by 3 days. Total S-opsin(+) cones in the PFA for LIP-treated and fellow-retinas were 2330 ± 262 and 5601 ± 583 (n = 8), respectively. All neuroprotectants (n = 7-11), including topical BMD pre- or post-LIP, or intravitreal BDNF, CNTF, and bFGF, showed significantly greater S-opsin(+) cone survival than their corresponding vehicle-treated groups. CONCLUSIONS: LIP is a reliable, quantifiable focal photoreceptor degeneration model. Topical BMD or intravitreal BDNF, CNTF, or bFGF protect against LIP-induced cone-photoreceptor loss. TRANSLATIONAL RELEVANCE: Topical BMD or intravitreal BDNF, CNTF, or bFGF protect cones against phototoxicity. | |
| dc.language.iso | eng | |
| dc.publisher | ASSOC RESEARCH VISION OPHTHALMOLOGY INC | |
| dc.rights | Atribución/Reconocimiento-NoComercial-SinDerivados 4.0 Internaciona | |
| dc.rights.uri | http://creativecommons.org/licenses/by-nc-nd/4.0/ | * |
| dc.title | Topical Brimonidine or Intravitreal BDNF, CNTF, or bFGF Protect Cones Against Phototoxicity | |
| dc.type | info:eu-repo/semantics/article | |
| dc.identifier.pmid | 31890348 | |
| dc.relation.publisherversion | https://tvst.arvojournals.org/article.aspx?articleid=2757559 | |
| dc.type.version | info:eu-repo/semantics/publishedVersion | |
| dc.identifier.doi | 10.1167/tvst.8.6.36 | |
| dc.journal.title | Translational Vision Science & Technology |